This therapeutic is a engineered antibody primarily targeting MUC1, a glycoprotein frequently overexpressed in various cancers , including lung cancer. Its mode of function involves binding to MUC1, https://cantuzumabresearchgrade556496.blognody.com/52096468/cantuzumab-a-deep-dive-into-the-anti-muc1-antibody